Why the study?
Ischemia-reperfusion injury is a complex pathology for which satisfactory, clinically translatable treatments remain challenging to develop.
This review highlights the therapeutic potential of the protein DJ-1 in the pathophysiology of ischemia-reperfusion injury.
Answers are grounded in this paper and cite their sources.
No immediate practice change in ischemia-reperfusion injury; leaves open targeted validation of DJ-1 modulation.
DJ-1 is a multifaceted protein with pleiotropic functions that has been implicated in multiple diseases, ranging from neurodegeneration to cancer and ischemia-reperfusion injury. Ischemia is a complex pathological state arising when tissues and organs do not receive adequate levels of oxygen and nutrients. When the blood flow is restored, significant damage occurs over and above that of ischemia alone and is termed ischemia-reperfusion injury. Despite great efforts in the scientific community to ameliorate this pathology, its complex nature has rendered it challenging to obtain satisfactory treatments that translate to the clinic. In this review, we will describe the recent findings on the participation of the protein DJ-1 in the pathophysiology of ischemia-reperfusion injury, firstly introducing the features and functions of DJ-1 and, successively highlighting the therapeutic potential of the protein.
No takes yet. Share an insight, caveat, or question.
Lazzari et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: